In December, the FDA approved the first oral antiviral https://www.fda.gov/news-events/press-announcements/coronavirus-covid-19-update-fda-authorizes-first-oral-antiviral-treatment-covid-19 for the treatment of mild-to-moderate coronavirus disease (COVID-19) in adults and pediatric patients (12 years of age and older weighing at least 40 kilograms or about 88 pounds) with positive results of direct SARS-CoV-2 testing, and who are at high risk for progression to severe COVID-19, including hospitalization or death. A limited number of FQHCs in Pennsylvania have begun to receive a supply of oral antivirals. Pennsylvania locations with oral antivirals obtained through the PA Department of health can be found at: https://www.health.pa.gov/topics/disease/coronavirus/Pages/Prevention-Treatment.aspx#oral Scroll down the page and note there are separate links for Mulnupiravir providers and Paxlovid providers. Individuals can also search by address using this therapeutics map: https://protect-public.hhs.gov/pages/therapeutics-distribution In addition, around 200 health centers nationwide, including seven in Pennsylvania, have been invited to participate in the HRSA program to distribute oral antivirals. As supply increases, oral AVs should be a more accessible solution, but supply is currently very limited in both programs.

The COVID-19 pandemic prompted the increased and widespread use of virtual health services, including telehealth, in health centers. Learn more about the effect that the rise in the use of this technology has had on clinician engagement through a STAR Center white paper. https://chcworkforce.org/web_links/effects-of-virtual-care-delivery/

A recent study of more than one million people confirms that COVID-19 vaccines are highly effective against COVID-19-associated hospitalization and death. Highlights include that severe COVID-19-associated outcomes (0.015%) or death (0.0033%) were rare and nearly 80% of those who died had at least four risk factors. https://www.cdc.gov/mmwr/volumes/71/wr/mm7101a4.htm

Pennsylvania Governor Tom Wolf announced the state is working to increase healthcare capacity to deal with the surge of COVID-19 cases. The Pennsylvania Department of Health and the Pennsylvania Emergency Management Agency are coordinating the undertaking. The plans involve adding hospital beds within regions for 60 days to absorb patients from swamped hospitals. Additional medical support staff are to include physicians, respiratory therapists and registered nurses. Other staff will be sent directly to hospitals in need over the next three months. Certain nursing homes also will get additional beds, registered nurses and aides to allow hospitals in the area to discharge patients in need of long-term rehab or care more quickly, according to an Associated Press report.

President Biden announced that, starting January 19th, the Administration will begin distributing at-home, rapid COVID-19 tests to American homes for free at COVIDTests.gov. This program will ensure that Americans have at-home, rapid COVID-19 tests available in the weeks and months ahead—in addition to the number of other ways they can get tested. The Administration is quickly completing a contracting process for the unprecedented purchase of one billion at-home, rapid tests to distribute as part of this program. You can find more details below about how to order an at-home test, and we encourage you to share this information broadly with your communities.

• Ordering Process: Starting on January 19, Americans will be able to order a test online at COVIDTests.gov. To ensure broad access, the program will limit the number of tests sent to each residential address to four tests. Tests will usually ship within 7-12 days of ordering.
• Distribution and Delivery Process: The Administration will partner with the United States Postal Service to package and deliver tests to Americans that want them. All orders in the continental United States will be sent through First Class Package Service, with shipments to Alaska, Hawaii, and the U.S. Territories and APO/FPO/DPO addresses sent through Priority Mail.

Ensuring Equity and Reaching Hardest-Hit Communities: The Administration is taking a number of steps to ensure this program reaches our hardest-hit and highest-risk communities. This includes prioritizing processing orders to households experiencing the highest social vulnerability and in communities that have experienced a disproportionate share of COVID-19 cases and deaths, particularly during this Omicron surge; launching a free call line, so that Americans who have difficulty accessing the internet or need additional support can phone-in orders for their tests; and, working with national and local organizations with deep experience serving communities of color, people living with disabilities, and other high-risk communities to serve as navigators, raise awareness about the program, and help people submit requests.